| Literature DB >> 10902630 |
G P Taylor, E G Lyall, D Back, C Ward, G Tudor-Williams.
Abstract
Given as a single dose to the mother during labour, nevirapine can protect the neonate from HIV-1 infection for up to 7 days. However, after maternal nevirapine therapy during pregnancy, neonatal plasma concentrations of nevirapine decline more rapidly, suggesting in-utero liver enzyme induction.Entities:
Mesh：
Substances：
Year: 2000 PMID： 10902630 DOI： 10.1016/s0140-6736(00)02383-7
Source DB: PubMed Journal: Lancet ISSN： 0140-6736 Impact factor: 79.321